GlassScriptPhysician profile
John Henry Velyvis
NPI 1740293216
$4,331.45
in general payments reported to CMS, 2019-2025
15 companies · $95.54 in 2025
The $95.54 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $18.24 · 2021: $3,467 · 2022: $320 · 2023: $124 · 2024: $122 · 2025: $95.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,416.89 | 2021 | |
| Stryker Corporation | $317.55 | 2019-2023 | Triathlon, Accolade |
| Zimmer Biomet Holdings, INC. | $146.39 | 2019-2022 | |
| Bioventus LLC | $103.33 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $100.89 | 2019-2025 | Monovisc |
| Amgen INC. | $53.90 | 2022-2023 | Evenity, Prolia |
| Linvatec Corporation | $37.20 | 2025 | Biobrace 23mm |
| Globus Medical, INC. | $25.39 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.73 | 2024 | Zilretta, Iovera, Exparel |
| Si-Bone, INC. | $23.55 | 2024 | |
| Heron Therapeutics, INC. | $23.18 | 2023 | Zynrelef |
| Heraeus Medical, LLC. | $22.29 | 2019 | |
| Kci USA, INC. | $18.24 | 2020 | |
| Convatec INC. | $17.92 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,279,537.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Velyvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.